CEOs have more angst about disruption than non-CEOs
Over 60% of CEOs surveyed by AlixPartners are worried their executive teams aren't agile enough to navigate today's fast pace of change.
Stay updated with breaking news from David Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over 60% of CEOs surveyed by AlixPartners are worried their executive teams aren't agile enough to navigate today's fast pace of change.
Eli Lilly CEO David Ricks on Monday said the company's powerful weight-loss drug Zepbound hit 25,000 new prescriptions per week at the end of December, and that its 2024 supply may not be enough to meet demand. "I think it's important to set expectations, but we're working hard to fulfill demand," he told Reuters at the annual JPMorgan health conference in San Francisco. Ricks declined to provide details on how much Zepbound Lilly can produce now, or to forecast 2024 demand and eventual supply.
The maker of Zepbound and Mounjaro launched a new platform to connect patients and prescribers.
CNBC’s Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference.
CNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference.